BrightRock Gold Corp (BRGC)

[Johnny4profits]

And the bottom plays will be @ ...................

I'd suggest that this may fall as low as the 0.03s or 0.04s before some real bottoming trading value is established. Phase lll trials are a very very very long ways off. This eight day old PR read nicely, but............. Anyhow, robots in the works! :)

National Pharmaceuticals Corp. in Association With Globe Labs to Enter Into Discussion on Clinical Trials Protocols for GLB333
8 days 20 hours 40 minutes ago - CCN via Comtex
Marketwire Canada
National Pharmaceuticals Corp. (PINK SHEETS:NFRM) or the "Company" announced today that in conjunction with Globe Laboratories have identified a contract research organization (CRO) from Europe to develop protocols for clinical trials of GLB333. Parties have decided that the Clinical Investigations group from Vienna, Austria would be most suitable for conducting the Phase I clinical trials. The trials which would be the first for GLB333 shall focus on the ability of the drug to speed up wound healing in diabetes patients suffering from chronic wound and tissue efflux.

I haven't done my homework yet to see if there is anything else with any substance holding this PPS up. If not, who is to say that sub-penny is not possible? Even possibly the TRIPLE ZEROS! Not that I would expect that, but................

I see that there is no MOD here at this time. I'm going to guess that the SS is current, but wouldn't assume it until verified.
Share Structure
O/S 95,093,710 a/o Sep 30, 2010
Float 40,093,710 a/o Sep 30, 2010
A/S 100,000,000 a/o Sep 30, 2010

With the following from the iBox, I would wonder how the potential earnings and costs come into play with the medical research and qualifications as an economic aid assisting with reducing the need for dilution. Also, with just a 100mil A/S, NFRM would have to raise their A/S to dilute to any degree and until I would get wind of that happening, it appears that there is a reasonable ceiling on dilution, which may be pretty closely watched.

MIAMI, FLORIDA, Dec 08, 2010 (MARKETWIRE via COMTEX) -- National Pharmaceuticals Corporation (PINK SHEETS: NFRM) is pleased to announce the appointment of Elaine Affleck as its new President and CEO. Ms. Affleck has been a Board Member of NFRM.PK. Ms. Affleck has served on several other boards in the past and brings her extensive business and accounting knowledge in assisting NFRM.PK to implement its future business plans.

NFRM.PK also is pleased to announce that it has entered into a Letter of Intent (LOI) to acquire a certain Proprietary Robotic technology from Excelco Systems International. Most robotic applications are singular processes where a single arm of Robot applies a pre-determined task. Most of the public can relate to this by watching the singular Robot applying welding on the car manufacturing assembly-lines. Excelco has developed a multi arm Robotic Technology that can easily do multiple applications at the same time therefore increasing efficiencies of any type of assembly lines or packaged goods manufacturing for Medical, Pharmaceutical, Food and many other industries. More details of the Robotic Technology will be provide once the LOI becomes a definitive Agreement.

National Pharmaceuticals is set to be recognized as a market leader committed to reducing supply chain costs by application of Robotic Automation to medical, institutional, Food and packaging industries.

Interesting company business platform. While I am very leery of these PPS levels as I find them unreal, I will be watching NFRM closely. Elaine Affleck as the new President and CEO is the figure to research and watch closely. Here skill or lack of skill will either make or break this deal.





NOTE: IMO not intended as investment advice. Be sure to do your own duh duh ("DD"). GL